Gain Therapeutics' lead drug candidate, GT-02287, is in clinical development for the treatment of Parkinson's disease (PD) with or without a GBA1 mutation. The orally administered, brain-penetrant ...

Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the ...

Find the most affordable desktop computer for home office work, creative tasks, and light PC gaming. Ready-made budget desktop computers are the most straightforward option for picking up an ...

One of Canada’s fastest-growing franchises has opened shop in the East Valley, bringing high-quality fast-casual, family-friendly Japanese cuisine.